Cancer isn't just a medical issue. It's a public policy issue. That's why the American Cancer Society Cancer Action NetworkSM (ACS CAN), the American Cancer Society's nonprofit, nonpartisan advocacy affiliate, engages with elected and appointed officials, policymakers, and candidates to ensure that cancer remains a top local, state, and national priority. ACS CAN's advocacy work is helping the American Cancer Society lead the fight for a world without cancer.
A coalition of the country’s leading public health advocacy organizations filed a friend-of-the-court brief in Texas v. Mayorkas in the United States District Court for the Southern District of Texas to urge the court to uphold the Biden administration’s 2022 “public charge” policy. Amici include American Cancer Society; American Cancer Society Cancer Action Network (ACS CAN); American Lung Association; CancerCare; Epilepsy Foundation; Hemophilia Federation of America; Leukemia & Lymphoma Society; Muscular Dystrophy Association; National Multiple Sclerosis Society; National Patient Advocate Foundation; and Susan G. Komen.
Barbara Behal recibió el premio Líder del Año del Equipo Constituyente de Embajadores (ACT) otorgado por la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) por su excepcional compromiso con la labor de defensa y por hacer del cáncer una prioridad nacional.
Gov. Greg Abbott signed legislation that will improve access to care for cancer patients and people with other conditions by expanding coverage for biomarker testing. Senate Bill 989 will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine treatments.
Do you have a personal story about how cancer has impacted you or someone you love? Real stories are how ACS CAN ensures that no one becomes a statistic.